The combination of classical Hodgkin's lymphoma (cHL) and non-Hodgkin lymphoma coexisting in the same patient is not common, especially in one extranodal location. Here we present a rare case of composite diffuse large B-cell lymphoma (DLBCL) and cHL occurring simultaneously in the stomach of a 53-year-old female who presented with upper abdominal discomfort and gas pain. Surgery was performed and the disease was diagnosed pathologically as composite lymphoma of DLBCL and cHL using hematoxylin-eosin and immunohistochemical staining. Epstein-Barr virus (EBV) infection was not detected by in situ hybridization for EBV-encoded RNA or immunohistochemistry for EBV latent membrane protein-1. Polymerase chain reaction analysis from the two distinct components of the tumor demonstrated clonal immunoglobulin κ light chain gene rearrangements. The patient died approximately 11 mo after diagnosis in spite of receiving eight courses of the CHOP and two courses of the rituximab-CHOP (RCHOP) chemotherapy regimen. This case report showed that the two distinct components, DLBCL and cHL, appeared to originate from the same clonal progenitor cell, and that EBV infection was not essential for transformation during the course of tumorigenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787365 | PMC |
| http://dx.doi.org/10.3748/wjg.v19.i37.6304 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary head and neck lymphoid neoplasms in adolescents and young adults: demographics, distribution and survival outcomes.
Ann Hematol
December 2024
Medical Center of Hematology, Xinqiao Hospital, Army Medical University, No.83 Xinqiao Road, Chongqing, 400037, China.
Primary head and neck lymphoid neoplasms(PHNLN) are described as a series of lymphoid system-derived neoplasms which originally arising from head and neck region. Our study is aimed to present a panoramic view of PHNLN among adolescent and young adult(AYA) patients aged from 15 to 39 years-old. The individual patient information was obtained from Surveillance, Epidemiology and End Results(SEER) database.
View Article and Find Full Text PDFEpstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: Diagnostic overlaps and defining features.
Hum Pathol
November 2024
Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Lineberger Comprehensive Cancer Center, 160 Medical Drive, Brinkhouse-Bullitt Building, CB#7525, Chapel Hill, NC, 27599, USA. Electronic address:
This review explores four Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders (LPD) and lymphomas with significant diagnostic overlap: EBV(+) mucocutaneous ulcer (EBVMCU), EBV(+) polymorphic LPD, EBV(+) classic Hodgkin lymphoma (CHL), and EBV(+) diffuse large B-cell lymphoma (DLBCL). Each entity is compared for both overlapping and defining features of clinical presentation, morphology, immunohistochemical profile and EBV expression pattern and latency. Our aims for this review are to provide useful guidance to the practicing pathologist in the diagnosis of these EBV-associated entities.
View Article and Find Full Text PDF3D-Q-FISH/Telomere/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma.
Cells
October 2024
Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
The bi- or multinucleated Reed-Sternberg cell (RS) is the diagnostic cornerstone of Epstein-Barr Virus (EBV)-positive and EBV-negative classical Hodgkin lymphoma (cHL). cHL is a germinal center (GC)-derived B-cell disease. Hodgkin cells (H) are the mononuclear precursors of RS.
View Article and Find Full Text PDFTransition From Epstein-Barr Virus (EBV)-Positive Rectal Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma in the Lung.
Cureus
July 2024
Pathology and Laboratory Medicine, University of Kentucky College of Medicine, Lexington, USA.
We report a distinctive case of sequential lymphomas in a 72-year-old male, initially diagnosed with Epstein-Barr virus (EBV)-positive rectal classic Hodgkin lymphoma (cHL), followed by the development of diffuse large B cell lymphoma (DLBCL) in the lung. This rare progression underscores the complexity of lymphomas associated with EBV infection and their unpredictable clinical courses. The patient's journey began with symptoms of intractable diarrhea, low appetite, and significant weight loss, leading to the diagnosis of stage 4B cHL, managed initially with brentuximab/doxorubicin, vinblastine, dacarbazine (AVD) chemotherapy.
View Article and Find Full Text PDFTranscriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation.
Nat Commun
August 2024
Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ, USA.
Article Synopsis
- Immunochemotherapy is currently the primary treatment for newly diagnosed diffuse large B-cell lymphoma (ndDLBCL), but it's ineffective for some patients, prompting research into better prognostic methods.
- By analyzing transcriptomic data from a large group of patients, researchers identified seven distinct clusters of ndDLBCL, with one specific cluster (A7) linked to poorer outcomes due to characteristics like low immune cell presence and high MYC expression.
- The study also explores how certain drugs, like lenalidomide, may improve treatment for the high-risk A7 cluster by enhancing T-cell movement into tumors and the expression of key tumor markers, while identifying TCF4 as a crucial factor in MYC biology for this group.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!